litlas
ログインアカウント作成

John A. Thompson

1975–2026 年に発表

別表記
John A Thompson · John A.Thompson
208
論文数
51,122
被引用数
107
h 指数
195
i10 指数

被引用数

John A. Thompson の年別被引用数1956 年: 被引用 1 件1975 年: 被引用 1 件1976 年: 被引用 1 件1977 年: 被引用 3 件1978 年: 被引用 1 件1979 年: 被引用 1 件1981 年: 被引用 2 件1982 年: 被引用 1 件1983 年: 被引用 2 件1984 年: 被引用 2 件1985 年: 被引用 3 件1986 年: 被引用 5 件1987 年: 被引用 6 件1988 年: 被引用 26 件1989 年: 被引用 26 件1990 年: 被引用 46 件1991 年: 被引用 45 件1992 年: 被引用 36 件1993 年: 被引用 26 件1994 年: 被引用 21 件1995 年: 被引用 29 件1996 年: 被引用 40 件1997 年: 被引用 71 件1998 年: 被引用 94 件1999 年: 被引用 116 件2000 年: 被引用 167 件2001 年: 被引用 212 件2002 年: 被引用 252 件2003 年: 被引用 303 件2004 年: 被引用 299 件2005 年: 被引用 313 件2006 年: 被引用 292 件2007 年: 被引用 314 件2008 年: 被引用 318 件2009 年: 被引用 359 件2010 年: 被引用 394 件2011 年: 被引用 400 件2012 年: 被引用 329 件2013 年: 被引用 397 件2014 年: 被引用 297 件2015 年: 被引用 317 件2016 年: 被引用 258 件2017 年: 被引用 291 件2018 年: 被引用 354 件2019 年: 被引用 1,194 件2020 年: 被引用 1,506 件2021 年: 被引用 1,473 件2022 年: 被引用 1,287 件2023 年: 被引用 1,034 件2024 年: 被引用 1,694 件2025 年: 被引用 698 件2026 年: 被引用 26 件1957〜1974 年は被引用が無いため表示していません1980 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 6,279 件、この内訳の 32.4%中国: 引用元論文 1,657 件、この内訳の 8.6%ドイツ: 引用元論文 1,124 件、この内訳の 5.8%イギリス: 引用元論文 1,023 件、この内訳の 5.3%イタリア: 引用元論文 986 件、この内訳の 5.1%フランス: 引用元論文 824 件、この内訳の 4.2%オーストラリア: 引用元論文 650 件、この内訳の 3.4%日本: 引用元論文 637 件、この内訳の 3.3%カナダ: 引用元論文 589 件、この内訳の 3%オランダ: 引用元論文 533 件、この内訳の 2.7%スペイン: 引用元論文 489 件、この内訳の 2.5%スイス: 引用元論文 477 件、この内訳の 2.5%
0%32.4%その他 21.2%

機関

分野

  • Medicine64.7%
  • Biochemistry, Genetics and Molecular Biology15.9%
  • Immunology and Microbiology11.3%
  • Computer Science2.4%
  • Engineering1.1%
  • Neuroscience1%
  • その他3.6%

トピック

  • Cancer Immunotherapy and Biomarkers10.2%
  • Immunotherapy and Immune Responses5.7%
  • CAR-T cell therapy research5.4%
  • Cutaneous Melanoma Detection and Management3.3%
  • Immune Cell Function and Interaction3.3%
  • Melanoma and MAPK Pathways2.3%
  • その他69.8%

共著者

全論文

検索で開く
  1. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update

    著者: Bryan J. Schneider, Jarushka Naidoo, Bianca D. Santomasso, Christina Lacchetti, Sherry Adkins, Milan Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino, Ian Chau, Marianne J. Davies, Marc S. Ernstoff, Leslie Fecher, Monalisa Ghosh, Ishmael Jaiyesimi, Jennifer S. Mammen, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura D. Porter, Cristina A. Reichner, Carole Seigel, Jung-Min Song, Alexander Spira, Maria Suarez-Almazor, Umang Swami, John A. Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S. Weber, Pauline Funchain, Kathryn Bollin - Journal of Clinical Oncology 2021 被引用: 1,964

  2. Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

    著者: Filipe Martins, Sofiya Latifyan, Gerasimos P. Sykiotis, Faïza Lamine, Michel H. Maillard, Montserrat Fraga, Keyvan Shabafrouz, Camillo Ribi, Anne Cairoli, Yan Guex‐Crosier, Thierry Küntzer, Olivier Michielin, Solange Peters, George Coukos, François Spertini, John A. Thompson, Michel Obéid - Nature Reviews Clinical Oncology 2019 被引用: 2,242

  3. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline

    著者: Julie R. Brahmer, Christina Lacchetti, Bryan J. Schneider, Michael B. Atkins, Kelly Brassil, Jeffrey M. Caterino, Ian Chau, Marc S. Ernstoff, Jennifer M. Gardner, Pamela Ginex, Sigrun Hallmeyer, Jennifer Holter Chakrabarty, Natasha B. Leighl, Jennifer S. Mammen, David F. McDermott, Aung Naing, Loretta J. Nastoupil, Tanyanika Phillips, Laura Porter, Igor Puzanov, Cristina Reichner, Bianca Santomasso, Carole Seigel, Alexander I. Spira, María E. Suarez‐Almazor, Yinghong Wang, Jeffrey S. Weber, Jedd D. Wolchok, John A. Thompson - Journal of Clinical Oncology 2018 被引用: 3,697

  4. Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology

    著者: John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Amaka Achufusi, Philippe Armand, Meghan Berkenstock, Shailender Bhatia, Lihua E. Budde, Saurin Chokshi, Marianne Davies, Amro Elshoury, Yaron Gesthalter, Aparna Hegde, Michael D. Jain, Benjamin H. Kaffenberger, Melissa G. Lechner, Tianhong Li, Alissa Marr, Suzanne McGettigan, Jordan P. McPherson, Theresa Medina, Nisha Mohindra, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Pradnya D. Patil, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Vlad G. Zaha, Megan Lyons, Mary A. Dwyer, Lisa Hang - Journal of the National Comprehensive Cancer Network 2022 被引用: 418

  5. Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline

    著者: Bianca D. Santomasso, Loretta J. Nastoupil, Sherry Adkins, Christina Lacchetti, Bryan J. Schneider, Milan Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino, Ian Chau, Marianne J. Davies, Marc S. Ernstoff, Leslie Fecher, Pauline Funchain, Ishmael Jaiyesimi, Jennifer S. Mammen, Jarushka Naidoo, Aung Naing, Tanyanika Phillips, Laura D. Porter, Cristina A. Reichner, Carole Seigel, Jung-Min Song, Alexander Spira, Maria Suarez-Almazor, Umang Swami, John A. Thompson, Praveen Vikas, Yinghong Wang, Jeffrey S. Weber, Kathryn Bollin, Monalisa Ghosh - Journal of Clinical Oncology 2021 被引用: 376

  6. PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma

    著者: Paul Nghiem, Shailender Bhatia, Evan J. Lipson, Ragini R. Kudchadkar, Natalie Miller, Lakshmanan Annamalai, Sneha Berry, Elliot Chartash, Adil Daud, Steven P. Fling, Philip Friedlander, Harriet M. Kluger, Holbrook E. Kohrt, Lisa Lundgren, Kim Margolin, Alan Mitchell, Thomas Olencki, Drew M. Pardoll, Sunil Reddy, Erica Shantha, William H. Sharfman, Elad Sharon, Lynn Shemanski, Michi M. Shinohara, Joel Sunshine, Janis M. Taube, John A. Thompson, Steven M. Townson, Jennifer H. Yearley, Suzanne L. Topalian, Martin A. Cheever - New England Journal of Medicine 2016 被引用: 1,243

  7. NCCN Guidelines Insights: Management of Immunotherapy-Related Toxicities, Version 1.2020

    著者: John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Benjamin H. Kaffenberger, Matthew A. Lunning, Suzanne McGettigan, Jordan P. McPherson, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Nathan A. Pennell, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Yinghong Wang, Ryan Weight, Alyse Johnson-Chilla, Griselda Zuccarino-Catania, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2020 被引用: 486

  8. Guidelines of care for the management of primary cutaneous melanoma

    著者: Susan M. Swetter, Hensin Tsao, Christopher K. Bichakjian, Clara Curiel‐Lewandrowski, David E. Elder, Jeffrey E. Gershenwald, Valerie Guild, Jane M. Grant‐Kels, Allan C. Halpern, Timothy M. Johnson, Arthur J. Sober, John A. Thompson, Oliver J. Wisco, Samantha Wyatt, Shasa Hu, Toyin Lamina - Journal of the American Academy of Dermatology 2018 被引用: 708

  9. Neoantigen-specific CD4+ T cells in human melanoma have diverse differentiation states and correlate with CD8+ T cell, macrophage, and B cell function

    著者: Joshua Veatch, Sylvia M. Lee, Carolyn Shasha, Naina Singhi, Julia Szeto, Ata S. Moshiri, Teresa S. Kim, Kimberly S. Smythe, Paul Kong, Matthew Fitzgibbon, Brenda L. Jesernig, Shailender Bhatia, Scott S. Tykodi, Evan Hall, David R. Byrd, John A. Thompson, Venu G. Pillarisetty, Thomas Duhen, A. McGarry Houghton, Evan W. Newell, Raphaël Gottardo, Stanley R. Riddell - Cancer Cell 2022 被引用: 144

  10. Management of Immunotherapy-Related Toxicities, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology

    著者: John A. Thompson, Bryan J. Schneider, Julie R. Brahmer, Stephanie Andrews, Philippe Armand, Shailender Bhatia, Lihua E. Budde, Luciano J. Costa, Marianne Davies, David Dunnington, Marc S. Ernstoff, Matthew J. Frigault, Brianna Hoffner, Christopher Hoimes, Mario E. Lacouture, Frederick L. Locke, Matthew A. Lunning, Nisha Mohindra, Jarushka Naidoo, Anthony J. Olszanski, Olalekan O. Oluwole, Sandip Pravin Patel, Sunil Reddy, Mabel Ryder, Bianca Santomasso, Scott Shofer, Jeffrey A. Sosman, Momen M. Wahidi, Yinghong Wang, Alyse Johnson-Chilla, Jillian L. Scavone - Journal of the National Comprehensive Cancer Network 2019 被引用: 560

  11. Efficacy of everolimus in advanced renal cell carcinoma: a double-blind, randomised, placebo-controlled phase III trial

    著者: Robert J. Motzer, Bernard Escudier, Stéphane Oudard, Thomas E. Hutson, Camillo Porta, Sergio Bracarda, Viktor Grünwald, John A. Thompson, Robert A. Figlin, Norbert Hollaender, Gladys Urbanowitz, William J. Berg, Andrea Kay, David Lebwohl, Alain Ravaud - The Lancet 2008 被引用: 3,012

  12. NCCN Guidelines® Insights: Melanoma: Cutaneous, Version 2.2021

    著者: Susan M. Swetter, John A. Thompson, Mark R. Albertini, Christopher A. Barker, Joel Baumgartner, Genevieve M. Boland, Bartosz Chmielowski, Dominick J. DiMaio, Alison B. Durham, Ryan C. Fields, Martin D. Fleming, Anjela Galan, Brian Gastman, Kenneth F. Grossmann, Samantha Guild, Ashley M. Holder, Douglas B. Johnson, Richard W. Joseph, Giorgos C. Karakousis, Kari Kendra, Julie R. Lange, Ryan M. Lanning, Kim Margolin, Anthony J. Olszanski, Patrick A. Ott, Merrick I. Ross, April K.S. Salama, Rohit Sharma, Joseph J. Skitzki, Jeffrey A. Sosman, Evan Wuthrick, Nicole R. McMillian, Anita M. Engh - Journal of the National Comprehensive Cancer Network 2021 被引用: 337

  13. Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

    著者: Fangwen Zou, David M. Faleck, Anusha Shirwaikar Thomas, Jessica Harris, Deepika Satish, Xuemei Wang, Aline Charabaty, Marc S. Ernstoff, Isabella C. Glitza Oliva, Stephen B. Hanauer, Jennifer L. McQuade, Michel Obéid, Amishi Y. Shah, David M. Richards, Elad Sharon, Jedd D. Wolchok, John A. Thompson, Yinghong Wang - Journal for ImmunoTherapy of Cancer 2021 被引用: 117

  14. Overall Survival and Updated Results for Sunitinib Compared With Interferon Alfa in Patients With Metastatic Renal Cell Carcinoma

    著者: Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak, M. Dror Michaelson, Ronald M. Bukowski, Stéphane Oudard, Sylvie Négrier, Cezary Szczylik, Роберто Пили, Georg A. Bjarnason, Xavier García del Muro, Jeffrey A. Sosman, E Solska, George Wilding, John A. Thompson, Sindy T. Kim, Isan Chen, Xin Huang, Robert A. Figlin - Journal of Clinical Oncology 2009 被引用: 2,189

  15. Age-Specific Incidence of Melanoma in the United States

    著者: Kelly G. Paulson, Deepti Gupta, Teresa S. Kim, Joshua Veatch, David R. Byrd, Shailender Bhatia, Katherine Y. Wojcik, Aude G. Chapuis, John A. Thompson, Margaret M. Madeleine, Jennifer M. Gardner - JAMA Dermatology 2019 被引用: 224

  16. First-in-human study of PC14586, a small molecule structural corrector of Y220C mutant p53, in patients with advanced solid tumors harboring a TP53 Y220C mutation.

    著者: Ecaterina E. Dumbrava, Melissa L. Johnson, Anthony W. Tolcher, Geoffrey I. Shapiro, John A. Thompson, Anthony B. El-Khoueiry, Andrae Lavon Vandross, Shivaani Kummar, Aparna R. Parikh, Pamela N. Münster, Erika Daly, Laura de Leon, Megan Khaddar, Kimberley LeDuke, Kimberly A. Robell, Lisa Iacono Sheehan, Meagen St. Louis, Amy E. Wiebesiek, Leila Alland, Alison M. Schram - Journal of Clinical Oncology 2022 被引用: 81

  17. Rechallenge patients with immune checkpoint inhibitors following severe immune-related adverse events: review of the literature and suggested prophylactic strategy

    著者: John B.A.G. Haanen, Marc S. Ernstoff, Yinghong Wang, Alexander M. Menzies, Igor Puzanov, Petros Grivas, James Larkin, Solange Peters, John A. Thompson, Michel Obéid - Journal for ImmunoTherapy of Cancer 2020 被引用: 167

  18. Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics

    著者: Kelly G. Paulson, Song Youn Park, Natalie Vandeven, Kristina Lachance, Hannah Thomas, Aude G. Chapuis, Kelly L. Harms, John A. Thompson, Shailender Bhatia, Andreas Stang, Paul Nghiem - Journal of the American Academy of Dermatology 2017 被引用: 504

  19. Autoimmune diseases and immune-checkpoint inhibitors for cancer therapy: review of the literature and personalized risk-based prevention strategy

    著者: John B.A.G. Haanen, Marc S. Ernstoff, Yinghong Wang, Alexander M. Menzies, Igor Puzanov, Petros Grivas, James Larkin, Solange Peters, John A. Thompson, Michel Obéid - Annals of Oncology 2020 被引用: 231

  20. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline Summary

    著者: Julie R. Brahmer, Christina Lacchetti, John A. Thompson - Journal of Oncology Practice 2018 被引用: 373

  21. MAGE-A3 immunotherapeutic as adjuvant therapy for patients with resected, MAGE-A3-positive, stage III melanoma (DERMA): a double-blind, randomised, placebo-controlled, phase 3 trial

    著者: Brigitte Dréno, John F Thompson, B. Mark Smithers, Mario Santinami, Thomas Jouary, Ralf Gutzmer, E. Levchenko, Piotr Rutkowski, Jean-Jacques Grob, S.I. Korovin, Kamil Drucis, Florent Grange, L. Machet, Peter Hersey, Ivana Krajsová, Alessandro Testori, Robert M. Conry, B. Guillot, Wim H.J. Kruit, Lev Demidov, John A. Thompson, Igor Bondarenko, Jarosław Jaroszek, Susana Puig, Gabriela Cinat, Axel Hauschild, Jelle J. Goeman, Hans C. van Houwelingen, Fernando Ulloa-Montoya, Andrea Callegaro, Benjamin Dizier, Bart Spiessens, Muriel Debois, Vincent Brichard, Jamila Louahed, Patrick Therasse, C. Debruyne, John M. Kirkwood - The Lancet Oncology 2018 被引用: 198

  22. A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors

    著者: Jeffrey S. Miller, Chihiro Morishima, Douglas G. McNeel, Manish R. Patel, Holbrook E. Kohrt, John A. Thompson, Paul M. Sondel, Heather A. Wakelee, Mary L. Disis, Judith C. Kaiser, Martin A. Cheever, Howard Streicher, S P Creekmore, Thomas A. Waldmann, Kevin C. Conlon - Clinical Cancer Research 2017 被引用: 195

  23. Treatment of Metastatic Melanoma with Autologous CD4+ T Cells against NY-ESO-1

    著者: Naomi Hunder, Herschel Wallen, Jianhong Cao, Deborah W. Hendricks, J. Zachary Reilly, Rebecca M. Rodmyre, Achim A. Jungbluth, Sacha Gnjatic, John A. Thompson, Cassian Yee - New England Journal of Medicine 2008 被引用: 905

  24. Prognostic Factors Analysis of 17,600 Melanoma Patients: Validation of the American Joint Committee on Cancer Melanoma Staging System

    著者: Charles M. Balch, Seng‐Jaw Soong, Jeffrey E. Gershenwald, John F. Thompson, Douglas S. Reintgen, Natale Cascinelli, Marshall M. Urist, Kelly M. McMasters, Merrick I. Ross, John M. Kirkwood, Michael B. Atkins, John A. Thompson, Daniel G. Coit, David R. Byrd, Renée A. Desmond, Yuting Zhang, Ping‐Yu Liu, Gary H. Lyman, Aberto Morabito - Journal of Clinical Oncology 2001 被引用: 2,401